TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35212749

Group type: EXPERIMENTAL
Intervention: Brief social contact-based video intervention featuring transgender adolescent girls
Number of subjects: 1437

Group type: EXPERIMENTAL
Intervention: Brief social contact-based video intervention featuring transgender adolescent boys
Number of subjects: 1437

Group type: EXPERIMENTAL
Intervention: Brief social contact-based video intervention featuring cisgender adolescent girls
Number of subjects: 1437

Group type: EXPERIMENTAL
Intervention: Brief social contact-based video intervention featuring cisgender adolescent boys
Number of subjects: 1437

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1437
Study: 33065817

Group type: EXPERIMENTAL
Intervention: Coping with Depression course with additional daily placebo treatment
Number of subjects: 126

Group type: COMPARATOR
Intervention: Coping with Depression course
Number of subjects: 126

Group type: COMPARATOR
Intervention: Waiting-list group
Number of subjects: 126
Study: 35597959

Group type: EXPERIMENTAL
Intervention: Self-guided digital treatment comprising psychoeducation and virtual reality exposure therapy (VRET) for 6 weeks, including one therapy session preparing for VRET and 4 weeks of self-guided VRET.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Relaxation and stress-reduction training (control group).
Number of subjects: 30
Study: 33561220

Group type: EXPERIMENTAL
Intervention: Walking initiated 20 minutes before the PPG peak (20iP)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Walking initiated at the PPG peak time (iP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sitting (SIT)
Number of subjects: 20
Study: 35137068

Group type: EXPERIMENTAL
Intervention: CoVideo (animated video on COVID-19 prevention)
Number of subjects: 15163

Group type: COMPARATOR
Intervention: Attention placebo control (APC) and do-nothing arms
Number of subjects: 15163
Study: 34114246

Group type: EXPERIMENTAL
Intervention: Strategies for enhancing medical record access
Number of subjects: 0
Study: 32858361

Group type: EXPERIMENTAL
Intervention: Positive airway pressure (PAP) therapy for at least three months (mean 377.6 ± 419.5 days)
Number of subjects: 1564
Study: 33462817

Group type: EXPERIMENTAL
Intervention: Hydraulic tomography (HT) with a randomized binary prior model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional pilot-point inversion scheme
Number of subjects: 0
Study: 32371401

Group type: EXPERIMENTAL
Intervention: LoDED strategy (limit of detection and ECG discharge)
Number of subjects: 629

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: LoDED strategy
Number of subjects: 629
Study: 36014787

Group type: EXPERIMENTAL
Intervention: 15% energy deficit diet and training (online intervention)
Number of subjects: 400
Study: 32831874

Group type: EXPERIMENTAL
Intervention: Five-Animal Frolics Exercise (FAE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine nursing care (Control Group)
Number of subjects: 0
Study: 34510643

Group type: EXPERIMENTAL
Intervention: 15-week group-based weight loss program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 60
Study: 33483123

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) - nine sessions
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) - nine sessions
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 80
Study: 32972271

Group type: EXPERIMENTAL
Intervention: Mindfulness-based program (MBP) plus diet
Number of subjects: 52

Group type: COMPARATOR
Intervention: Diet alone (Control)
Number of subjects: 52
Study: 34236101

Group type: EXPERIMENTAL
Intervention: Levodopa-Carbidopa Intestinal Gel (LCIG)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Oral Optimized Medical Treatment (OMT)
Number of subjects: 63
Study: 32150258

Group type: EXPERIMENTAL
Intervention: Stepped-care intervention
Number of subjects: 222

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 222
Study: 36229781

Group type: EXPERIMENTAL
Intervention: ANRC‐Essentials Plus (ANRC‐EP)
Number of subjects: 161
Study: 33405297

Group type: EXPERIMENTAL
Intervention: 140% Insulin-to-Carbohydrate Ratio (ICR)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 160% Insulin-to-Carbohydrate Ratio (ICR)
Number of subjects: 27

Group type: COMPARATOR
Intervention: 100% Insulin-to-Carbohydrate Ratio (ICR)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 120% Insulin-to-Carbohydrate Ratio (ICR)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Increasing insulin doses (100%-160% ICR)
Number of subjects: 27
Study: 32437174

Group type: EXPERIMENTAL
Intervention: EQuIP (Empowering Queer Identities in Psychotherapy)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 60
Study: 35984904

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 240
Study: 34092093

Group type: EXPERIMENTAL
Intervention: DA+DCB
Number of subjects: 80

Group type: COMPARATOR
Intervention: DCB
Number of subjects: 80
Study: 32609651

Group type: COMPARATOR
Intervention: Placebo interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacological and nonpharmacological treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients' perception and verbal suggestions for pain relief
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Expectations toward treatment effects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unintentional unblinding and patients' perception of treatment
Number of subjects: 0
Study: 36240100

Group type: EXPERIMENTAL
Intervention: Telestroke assessment
Number of subjects: 76

Group type: COMPARATOR
Intervention: PASTA assessment
Number of subjects: 76
Study: 32000419

Group type: EXPERIMENTAL
Intervention: Daesiho‐tang (DSHT)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Chowiseungcheng‐tang (CST)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 35596963

Group type: COMPARATOR
Intervention: Standard implementation
Number of subjects: 544

Group type: COMPARATOR
Intervention: Enhanced implementation
Number of subjects: 544
Study: 32419670

Group type: EXPERIMENTAL
Intervention: Trauma and the Body Group (TBG) - 20-session group psychotherapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 32
Study: 33259428

Group type: EXPERIMENTAL
Intervention: Video call
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Phone call
Number of subjects: 251

Group type: COMPARATOR
Intervention: No contact (standard of care)
Number of subjects: 251
Study: 35436329

Group type: EXPERIMENTAL
Intervention: Power training
Number of subjects: 103

Group type: COMPARATOR
Intervention: Low intensity sham exercise control
Number of subjects: 103
Study: 34161051

Group type: EXPERIMENTAL
Intervention: <sup>177</sup>Lu-PSMA-617 plus standard care
Number of subjects: 831

Group type: COMPARATOR
Intervention: <sup>177</sup>Lu-PSMA-617
Number of subjects: 831
Study: 34267583

Group type: EXPERIMENTAL
Intervention: TG4 (four weekly campus board training sessions)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: TG2 (two weekly campus board training sessions)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Merged training groups
Number of subjects: 16

Group type: COMPARATOR
Intervention: CG (control group)
Number of subjects: 16
Study: 33045833

Group type: EXPERIMENTAL
Intervention: PDCoV-infected IPEC-J2 cells
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Verification of DEPs (ANAPC7 and IFIT1)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Bioinformatics analyses
Number of subjects: 78
Study: 35342439

Group type: EXPERIMENTAL
Intervention: Synchronized Intermittent Mandatory Ventilation (SIMV)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Adaptive Support Ventilation (ASV)
Number of subjects: 24
Study: 36320825

Group type: EXPERIMENTAL
Intervention: Withholding methotrexate for 2 weeks after each dose of ChAdOx1 nCov‐19 vaccine (MIVAC I)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Withholding methotrexate for 2 weeks after the second dose of ChAdOx1 nCov‐19 vaccine (MIVAC II)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Continuation of methotrexate
Number of subjects: 250
Study: 34716893

Group type: EXPERIMENTAL
Intervention: Modified 3-day weekend frequency-volume chart (FVC)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: ICCS-recommended voiding diary
Number of subjects: 1200
Study: 36006791

Group type: EXPERIMENTAL
Intervention: End-of-life simulated scenario
Number of subjects: 0
Study: 35067125

Group type: EXPERIMENTAL
Intervention: Robotic assisted training (assisted motion, biofeedback, antagonist muscle vibration)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo intervention (designed to have no effect)
Number of subjects: 83
Study: 33630509

Group type: EXPERIMENTAL
Intervention: Adaptive Reserve (AR) measured by staff survey
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Quality Improvement Capacity Assessment (QICA)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Baseline AR
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Change in AR
Number of subjects: 142
Study: 32669306

Group type: EXPERIMENTAL
Intervention: Intensive systolic BP control (<120 mm Hg)
Number of subjects: 8885

Group type: COMPARATOR
Intervention: Standard systolic BP control (<140 mm Hg)
Number of subjects: 8885
Study: 36354243

Group type: EXPERIMENTAL
Intervention: 500 mg of magnesium daily (two 250-mg magnesium oxide tablets for five days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 60
Study: 33736542

Group type: EXPERIMENTAL
Intervention: Early rehabilitation (ER) group started exercising between 24 and 48 hours after stroke onset
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Early rehabilitation (ER) group
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard rehabilitation (SR) group started exercising between 72 and 96 hours after stroke onset
Number of subjects: 110
Study: 34881835

Group type: EXPERIMENTAL
Intervention: Oral semaglutide (Rybelsus®)
Number of subjects: 9543
Study: 32987642

Group type: EXPERIMENTAL
Intervention: Low-fat vegan diet
Number of subjects: 168
Study: 35345663

Group type: EXPERIMENTAL
Intervention: Temozolomide single agent and doxorubicin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Temozolomide capsules (control group)
Number of subjects: 70
Study: 34725095

Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 0
Study: 36079832

Group type: EXPERIMENTAL
Intervention: Higher dietary magnesium
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Higher dietary potassium
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Higher dietary calcium
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Higher dietary phosphorus
Number of subjects: 392
Study: 34495437

Group type: EXPERIMENTAL
Intervention: Prophylactic anticonvulsant use in both aSAH and sICH
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Prophylactic anticonvulsant use only in aSAH
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Prophylactic anticonvulsant use only in sICH
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Selective use of ASMs in sICH
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Prophylactic anticonvulsant use for all patients with aSAH
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Levetiracetam (Keppra) as the most commonly used ASM
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Willingness to randomize sICH patients to management with or without ASM prophylaxis
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Willingness to randomize aSAH patients to management with or without ASM prophylaxis
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Correct response to AHA/ASA Guidelines on prophylactic anticonvulsants in sICH
Number of subjects: 103
Study: 36441106

Group type: EXPERIMENTAL
Intervention: Sleep extension (EXT) intervention
Number of subjects: 175

Group type: COMPARATOR
Intervention: Family routines support (FRS) consultation
Number of subjects: 175
Study: 34382717

Group type: EXPERIMENTAL
Intervention: 150 mg of French maritime pine bark extract supplementation (Oligopin) with enteral nutrition for 10 days
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 32075663

Group type: EXPERIMENTAL
Intervention: Pre-operative package of non-operative care (weight-loss programme, exercises, advice on analgesia use, provision of insoles)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study: 33221341

Group type: EXPERIMENTAL
Intervention: AB2 (affinity-matured recombinant Fab inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: U33 (parental Fab)
Number of subjects: 0
Study: 32828924

Group type: EXPERIMENTAL
Intervention: EEG-based neurofeedback during shoulder motor imagery (MI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EEG-based neurofeedback during hand motor imagery (MI)
Number of subjects: 0
Study: 35137002

Group type: EXPERIMENTAL
Intervention: ABA10
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: ABA30/10
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 34154445

Group type: EXPERIMENTAL
Intervention: ED‐ASBI without GP follow‐up
Number of subjects: 453

Group type: COMPARATOR
Intervention: GP follow‐up
Number of subjects: 453
Study: 35339185

Group type: EXPERIMENTAL
Intervention: Quantitative susceptibility mapping (QSM)
Number of subjects: 400
Study: 34292213

Group type: EXPERIMENTAL
Intervention: Postural garment PosturePlusForce
Number of subjects: 32

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 32
Study: 33180798

Group type: EXPERIMENTAL
Intervention: Group-based resilience intervention (stress management and mindfulness tools), delivered in six sessions over six weeks.
Number of subjects: 430

Group type: COMPARATOR
Intervention: Psychoeducation (online stress and mental health education), delivered in six modules over six weeks.
Number of subjects: 430
Study: 36411968

Group type: EXPERIMENTAL
Intervention: PMC split-dose regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: PMC day-before regimen
Number of subjects: 0
Study: 32644304

Group type: EXPERIMENTAL
Intervention: PEAK PlasmaBlade™
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional electrosurgery
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 20
Study: 34967147

Group type: EXPERIMENTAL
Intervention: Trazpiroben 50 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Trazpiroben 100 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Trazpiroben 10 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 34904948

Group type: EXPERIMENTAL
Intervention: Return of PRO results
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Return of PRO results plus self‐management intervention
Number of subjects: 227

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 227
Study: 36279795

Group type: EXPERIMENTAL
Intervention: 1500 mg/kg HPβCD intravenously every 2 weeks for a total of 7 doses (14 weeks)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 2500 mg/kg HPβCD intravenously every 2 weeks for a total of 7 doses (14 weeks)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: HPβCD treatment
Number of subjects: 13
Study: 34805403

Group type: EXPERIMENTAL
Intervention: Hydroxyzine
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Hydroxyzine plus clowns
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo plus clowns
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Combination of hydroxyzine and clowns
Number of subjects: 165
Study: 33402123

Group type: EXPERIMENTAL
Intervention: Supportive counseling (6 sessions, 45–60 minutes each)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 66
Study: 32383736

Group type: EXPERIMENTAL
Intervention: Avatar-led intervention (Flexiquit)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 105
Study: 35193545

Group type: EXPERIMENTAL
Intervention: Enerisant 25 mg/day
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Enerisant 50 mg/day
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Enerisant 100 mg/day
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Enerisant 5 mg/day
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Enerisant 10 mg/day
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 33974688

Group type: EXPERIMENTAL
Intervention: Early high nutrition (EHN) - milk replacer (maximum intake of 1.8 kg/d) until 3 mo, then high-concentrate diet from 4 to 10 mo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Early high nutrition (EHN)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Roughage group (RG)
Number of subjects: 23
Study: 32809136

Group type: EXPERIMENTAL
Intervention: Conservative oxygen therapy
Number of subjects: 166

Group type: COMPARATOR
Intervention: Usual oxygen therapy
Number of subjects: 166
Study: 34957992

Group type: EXPERIMENTAL
Intervention: Combined handheld ultrasound and fluoroscopy-guided corticosteroid injection
Number of subjects: 39

Group type: COMPARATOR
Intervention: Conventional ultrasound-guided corticosteroid injection
Number of subjects: 39
Study: 32897182

Group type: EXPERIMENTAL
Intervention: Early mobilization
Number of subjects: 50

Group type: COMPARATOR
Intervention: Splinting
Number of subjects: 50
Study: 36235865

Group type: EXPERIMENTAL
Intervention: FibreMAX (two daily servings of 25 g of BARLEYmax®)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: FibreGRAD (two daily servings with the amount of fibre gradually increased)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (two daily servings totalling 25 g of placebo product)
Number of subjects: 38
Study: 33883012

Group type: EXPERIMENTAL
Intervention: Shared Decision-Making (SDM) approach
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Recruitment strategies informed by Theoretical Domains Framework (TDF)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Recruitment practices
Number of subjects: 9
Study: 32140704

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplement 10 µg
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplement 25 µg
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo (2 µg)
Number of subjects: 206
Study: 34663910

Group type: EXPERIMENTAL
Intervention: First-language instruction
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 230
Study: 34704722

Group type: EXPERIMENTAL
Intervention: Oblique (OB) approach
Number of subjects: 147

Group type: COMPARATOR
Intervention: Anteroposterior (AP) approach
Number of subjects: 147
Study: 34270620

Group type: EXPERIMENTAL
Intervention: 2 mA of anodal tDCS stimulation over the left dorsolateral prefrontal cortex for 20 minutes
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 48
Study: 33065547

Group type: EXPERIMENTAL
Intervention: hCG (500, 1500, and 5000 IU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conditioned medium (CM) from human endometrial stromal cells (ESC) stimulated with hCG
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 36355053

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo (first year) then Testosterone undecanoate (TU) (second year)
Number of subjects: 55
Study: 33213492

Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT) applied with 15–25% tension for 72 hours
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo taping without tension
Number of subjects: 30
Study: 34702946

Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells (MSCs)
Number of subjects: 58
Study: 33232454

Group type: EXPERIMENTAL
Intervention: Coronary Computed Tomography (CCT)
Number of subjects: 1980

Group type: COMPARATOR
Intervention: Stress Echocardiography (SE)
Number of subjects: 1980
Study: 35165819

Group type: EXPERIMENTAL
Intervention: Neurally adjusted ventilatory assist (NAVA)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation (SIMV)
Number of subjects: 8
Study: 33492484

Group type: EXPERIMENTAL
Intervention: Web-based surgical skill learning session (WSSL)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Face-to-face tutorials (control group)
Number of subjects: 62
Study: 32164771

Group type: EXPERIMENTAL
Intervention: CareConekta app plus text notifications and phone calls and/or WhatsApp messages
Number of subjects: 200
Study: 35339294

Group type: EXPERIMENTAL
Intervention: Nurse-led couples intervention plus routine nursing care
Number of subjects: 104

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 104
Study: 33478426

Group type: EXPERIMENTAL
Intervention: Phaco-UCP
Number of subjects: 61

Group type: COMPARATOR
Intervention: Phaco-along
Number of subjects: 61
Study: 32470921

Group type: EXPERIMENTAL
Intervention: PABC discussion session
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 35925203

Group type: EXPERIMENTAL
Intervention: Non‐Ach (beta‐3 agonists)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Anticholinergic
Number of subjects: 12
Study: 33825049

Group type: EXPERIMENTAL
Intervention: AIR score
Number of subjects: 3878
Study: 32879152

Group type: EXPERIMENTAL
Intervention: Selexipag
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Selexipag (in patients not using a pulmonary vasodilator)
Number of subjects: 28
Study: 32928020

Group type: EXPERIMENTAL
Intervention: Selective catheterization of bilateral uterine arteries and subsequent uterine embolization (EMB)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Elective cesarean section (CTR)
Number of subjects: 76
Study: 33512251

Group type: EXPERIMENTAL
Intervention: Honey-lemon spray
Number of subjects: 46

Group type: COMPARATOR
Intervention: Benzydamine hydrochloride spray
Number of subjects: 46
Study: 32315362

Group type: EXPERIMENTAL
Intervention: Integrated collaborative care intervention for obesity and depression
Number of subjects: 204

Group type: COMPARATOR
Intervention: Poor engagement in the intervention
Number of subjects: 204
Study: 35652933

Group type: EXPERIMENTAL
Intervention: Standard care with focus group participation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 18